Sep 27, 2021 05:05PM
Aug 9, 2021 04:05PM
Aug 9, 2021 04:05PM
Jul 6, 2021 04:54PM
Jul 6, 2021 08:30AM
Jul 6, 2021 08:30AM
Jul 6, 2021 08:30AM ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis
May 7, 2021 09:36AM
May 7, 2021 09:20AM
May 7, 2021 07:38AM
May 7, 2021 07:15AM
May 7, 2021 06:48AM
May 7, 2021 05:14AM
May 6, 2021 11:37PM ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
May 6, 2021 11:37PM
May 4, 2021 01:42PM
May 4, 2021 12:22PM
Apr 29, 2021 04:05PM
Apr 29, 2021 04:05PM
Sep 17, 2020 08:33AM
Sep 17, 2020 08:30AM ChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment of ANCA-Associated Vasculitis
Sep 17, 2020 08:30AM

15,627 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All